1. Market Research
  2. > Healthcare
  3. > Pathology
  4. > Mental Health Market Trends
  5. > Mental Health Analysis & Statistics in Spain, May 2019

Mental Health Analysis & Statistics in Spain, May 2019

1-30 of 96 reports

University of Barcelona - Pharmaceuticals & Healthcare - Deals and Alliances Profile

University of Barcelona - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • December 2018

SummaryUniversity of Barcelona is an educational university that offers bachelor’s degrees, master’s degrees and research doctoral studies.The university provides EHEA bachelor’s degree courses, ...

  • Industries : Pharmaceutical, Pathology
  • Countries : Spain
Spain Neurology Devices Market Outlook to 2025 - Hydrocephalus Shunts, Interventional Neuroradiology Devices, Neurosurgical Products and Others

Spain Neurology Devices Market Outlook to 2025 - Hydrocephalus Shunts, Interventional Neuroradiology Devices, Neurosurgical Products and Others

  • $ 5995
  • Industry report
  • November 2018

Spain Neurology Devices Market Outlook to 2025 - Hydrocephalus Shunts, Interventional Neuroradiology Devices, Neurosurgical Products and OthersSummaryGlobalData’s new report, Spain Neurology Devices ...

  • Industries : Health Services, Healthcare, Patient Monitoring, Medical Device, Mental Health, Pathology
  • Countries : Spain, Southern Europe
Oryzon Genomics SA (ORY) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Oryzon Genomics SA (ORY) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • October 2018

SummaryOryzon Genomics SA (Oryzon) is a clinical stage biopharmaceutical company that offers discovers and develops epigenetic therapies to treat oncology and neurodegenerative diseases.The company offers ...

  • Industries : Mental Health, Pathology, Medical Biotechnology
  • Countries : United States, Spain
Parkinson’s Disease: Epidemiology Forecast to 2026

Parkinson’s Disease: Epidemiology Forecast to 2026

  • $ 3995
  • Industry report
  • May 2018

Parkinson’s Disease: Epidemiology Forecast to 2026SummaryParkinson’s disease (PD) is the second most common chronic progressive neurodegenerative disorder in the elderly after Alzheimer’s disease, ...

  • Industries : Mental Health, Pathology
  • Countries : United States, United Kingdom, Japan, Spain, Germany
Drug Overview: Latuda

Drug Overview: Latuda

  • $ 10000
  • Industry report
  • April 2018

Drug Overview Latuda (lurasidone; Sumitomo Dainippon/Angelini) contains the atypical antipsychotic lurasidone, which acts as an antagonist of dopamine receptors D2, and serotonin receptors 5-HT2A. By ...

  • Industries : Mental Health, Pathology
  • Countries : United Kingdom, Italy, Japan, European Union, United States, Germany, Spain
EPIOMIC EPIDEMIOLOGY SERIES: EPILEPSY FORECAST IN 19 MAJOR MARKETS 2018–2028

EPIOMIC EPIDEMIOLOGY SERIES: EPILEPSY FORECAST IN 19 MAJOR MARKETS 2018–2028

  • $ 5577
  • Industry report
  • April 2018

Black Swan Analysis Epiomic™ Epidemiology Forecast Report on Epilepsy in 19 Major MarketsEpilepsy is a complex neurologic disorder characterised by the occurrence of seizures, divided into several types ...

  • Industries : Mental Health, Pathology
  • Countries : Italy, Spain, Poland, Germany, France
EpiCast Report: Alzheimer’s Disease - Epidemiology Forecast to 2026

EpiCast Report: Alzheimer’s Disease - Epidemiology Forecast to 2026

  • $ 3995
  • Industry report
  • October 2017

EpiCast Report: Alzheimer’s Disease - Epidemiology Forecast to 2026SummaryAlzheimer’s disease (AD) is a subtype of dementia and is an irreversible, neurodegenerative brain disease of the elderly, characterized ...

  • Industries : Mental Health, Pathology
  • Countries : United States, World, Spain, Japan, Italy, Germany, France, United Kingdom
Global Huntington’s Disease Epidemiology and Patient Flow Analysis - 2017

Global Huntington’s Disease Epidemiology and Patient Flow Analysis - 2017

  • $ 1790
  • Industry report
  • January 2017

Fore Pharma announced the results of its Huntington’s Disease patients study in a new report ‘Global Huntington’s Disease Epidemiology and Patient Flow Analysis - 2017’. The report provides insights ...

  • Industries : Mental Health, Pathology
  • Countries : World, United States, Germany, France, Spain, Italy, United Kingdom, Japan
Global Unipolar Depression Epidemiology and Patient Flow Analysis - 2017

Global Unipolar Depression Epidemiology and Patient Flow Analysis - 2017

  • $ 1790
  • Industry report
  • January 2017

Fore Pharma announced the results of its Unipolar Depression patients study in a new report ‘Global Unipolar Depression Epidemiology and Patient Flow Analysis - 2017’. The report provides insights ...

  • Industries : Mental Health, Pathology
  • Countries : World, United States, Germany, France, Spain, Italy, United Kingdom, Japan
Europe Bipolar Disorder Epidemiology and Patient Flow Analysis - 2017

Europe Bipolar Disorder Epidemiology and Patient Flow Analysis - 2017

  • $ 1390
  • Industry report
  • January 2017

Fore Pharma announced the results of its Bipolar Disorder patients study in a new report ‘Europe Bipolar Disorder Epidemiology and Patient Flow Analysis - 2017’. The report provides insights into Bipola ...

  • Industries : Mental Health, Pathology
  • Countries : Europe, Germany, France, Spain, Italy, United Kingdom
Europe Gaucher%s Disease Epidemiology and Patient Flow Analysis - 2017

Europe Gaucher%s Disease Epidemiology and Patient Flow Analysis - 2017

  • $ 1390
  • Industry report
  • January 2017

Fore Pharma announced the results of its Gaucher's Disease patients study in a new report ‘Europe Gaucher's Disease Epidemiology and Patient Flow Analysis - 2017’. The report provides insights into ...

  • Industries : Mental Health, Pathology
  • Countries : Europe, Germany, France, Spain, Italy, United Kingdom
Global Attention Deficit Hyperactivity Disorder Epidemiology and Patient Flow Analysis - 2017

Global Attention Deficit Hyperactivity Disorder Epidemiology and Patient Flow Analysis - 2017

  • $ 1790
  • Industry report
  • January 2017

Fore Pharma announced the results of its Attention Deficit Hyperactivity Disorder patients study in a new report ‘Global Attention Deficit Hyperactivity Disorder Epidemiology and Patient Flow Analysis ...

  • Industries : Mental Health, Pathology
  • Countries : World, United States, Germany, France, Spain, Italy, United Kingdom, Japan
Global Bipolar Depression Epidemiology and Patient Flow Analysis - 2017

Global Bipolar Depression Epidemiology and Patient Flow Analysis - 2017

  • $ 1790
  • Industry report
  • January 2017

Fore Pharma announced the results of its Bipolar Depression patients study in a new report ‘Global Bipolar Depression Epidemiology and Patient Flow Analysis - 2017’. The report provides insights into ...

  • Industries : Mental Health, Pathology
  • Countries : World, United States, Germany, France, Spain, Italy, United Kingdom, Japan
Europe Parkinson%s Disease Epidemiology and Patient Flow Analysis - 2017

Europe Parkinson%s Disease Epidemiology and Patient Flow Analysis - 2017

  • $ 1390
  • Industry report
  • January 2017

Fore Pharma announced the results of its Parkinson's Disease patients study in a new report ‘Europe Parkinson's Disease Epidemiology and Patient Flow Analysis - 2017’. The report provides insights ...

  • Industries : Mental Health, Pathology
  • Countries : Europe, Germany, France, Spain, Italy, United Kingdom
Europe Unipolar Depression Epidemiology and Patient Flow Analysis - 2017

Europe Unipolar Depression Epidemiology and Patient Flow Analysis - 2017

  • $ 1390
  • Industry report
  • January 2017

Fore Pharma announced the results of its Unipolar Depression patients study in a new report ‘Europe Unipolar Depression Epidemiology and Patient Flow Analysis - 2017’. The report provides insights ...

  • Industries : Mental Health, Pathology
  • Countries : Europe, Germany, France, Spain, Italy, United Kingdom
Global Epilepsy Epidemiology and Patient Flow Analysis - 2017

Global Epilepsy Epidemiology and Patient Flow Analysis - 2017

  • $ 1790
  • Industry report
  • January 2017

Fore Pharma announced the results of its Epilepsy patients study in a new report ‘Global Epilepsy Epidemiology and Patient Flow Analysis - 2017’. The report provides insights into Epilepsy epidemiology, ...

  • Industries : Mental Health, Pathology
  • Countries : United States, World, Germany, France, Spain, Italy, United Kingdom, Japan
Europe Epilepsy Epidemiology and Patient Flow Analysis - 2017

Europe Epilepsy Epidemiology and Patient Flow Analysis - 2017

  • $ 1390
  • Industry report
  • January 2017

Fore Pharma announced the results of its Epilepsy patients study in a new report ‘Europe Epilepsy Epidemiology and Patient Flow Analysis - 2017’. The report provides insights into Epilepsy epidemiology, ...

  • Industries : Mental Health, Pathology
  • Countries : Europe, Germany, France, Spain, Italy, United Kingdom
Europe Multiple Sclerosis Epidemiology and Patient Flow Analysis - 2017

Europe Multiple Sclerosis Epidemiology and Patient Flow Analysis - 2017

  • $ 1390
  • Industry report
  • January 2017

Fore Pharma announced the results of its Multiple Sclerosis patients study in a new report ‘Europe Multiple Sclerosis Epidemiology and Patient Flow Analysis - 2017’. The report provides insights into ...

  • Industries : Mental Health, Pathology
  • Countries : Europe, Germany, France, Spain, Italy, United Kingdom
Europe Obsessive Compulsive Disorder Epidemiology and Patient Flow Analysis - 2017

Europe Obsessive Compulsive Disorder Epidemiology and Patient Flow Analysis - 2017

  • $ 1390
  • Industry report
  • January 2017

Fore Pharma announced the results of its Obsessive Compulsive Disorder patients study in a new report ‘Europe Obsessive Compulsive Disorder Epidemiology and Patient Flow Analysis - 2017’. The report ...

  • Industries : Mental Health, Pathology
  • Countries : Europe, Germany, France, Spain, Italy, United Kingdom
Global Anxiety Disorder Epidemiology and Patient Flow Analysis - 2017

Global Anxiety Disorder Epidemiology and Patient Flow Analysis - 2017

  • $ 1790
  • Industry report
  • January 2017

Fore Pharma announced the results of its Anxiety Disorder patients study in a new report ‘Global Anxiety Disorder Epidemiology and Patient Flow Analysis - 2017’. The report provides insights into Anxiety ...

  • Industries : Mental Health, Pathology
  • Countries : World, United States, Germany, France, Spain, Italy, United Kingdom, Japan
Global Multiple Sclerosis Epidemiology and Patient Flow Analysis - 2017

Global Multiple Sclerosis Epidemiology and Patient Flow Analysis - 2017

  • $ 1790
  • Industry report
  • January 2017

Fore Pharma announced the results of its Multiple Sclerosis patients study in a new report ‘Global Multiple Sclerosis Epidemiology and Patient Flow Analysis - 2017’. The report provides insights into ...

  • Industries : Mental Health, Pathology
  • Countries : World, United States, Germany, France, Spain, Italy, United Kingdom, Japan
Global Schizophrenia Epidemiology and Patient Flow Analysis - 2017

Global Schizophrenia Epidemiology and Patient Flow Analysis - 2017

  • $ 1790
  • Industry report
  • January 2017

Fore Pharma announced the results of its Schizophrenia patients study in a new report ‘Global Schizophrenia Epidemiology and Patient Flow Analysis - 2017’. The report provides insights into Schizophrenia ...

  • Industries : Mental Health, Pathology
  • Countries : United States, World, Germany, France, Spain, Italy, United Kingdom, Japan
Europe Major Depression Epidemiology and Patient Flow Analysis - 2017

Europe Major Depression Epidemiology and Patient Flow Analysis - 2017

  • $ 1390
  • Industry report
  • January 2017

Fore Pharma announced the results of its Major Depression patients study in a new report ‘Europe Major Depression Epidemiology and Patient Flow Analysis - 2017’. The report provides insights into Majo ...

  • Industries : Mental Health, Pathology
  • Countries : Europe, Germany, France, Spain, Italy, United Kingdom
Europe Addiction Disorder Epidemiology and Patient Flow Analysis - 2017

Europe Addiction Disorder Epidemiology and Patient Flow Analysis - 2017

  • $ 1390
  • Industry report
  • January 2017

Fore Pharma announced the results of its Addiction Disorder patients study in a new report ‘Europe Addiction Disorder Epidemiology and Patient Flow Analysis - 2017’. The report provides insights into ...

  • Industries : Mental Health, Pathology
  • Countries : Europe, Germany, France, Spain, Italy, United Kingdom
Europe Bipolar Depression Epidemiology and Patient Flow Analysis - 2017

Europe Bipolar Depression Epidemiology and Patient Flow Analysis - 2017

  • $ 1390
  • Industry report
  • January 2017

Fore Pharma announced the results of its Bipolar Depression patients study in a new report ‘Europe Bipolar Depression Epidemiology and Patient Flow Analysis - 2017’. The report provides insights into ...

  • Industries : Mental Health, Pathology
  • Countries : Europe, Germany, France, Spain, Italy, United Kingdom
Global Panic Disorder Epidemiology and Patient Flow Analysis - 2017

Global Panic Disorder Epidemiology and Patient Flow Analysis - 2017

  • $ 1790
  • Industry report
  • January 2017

Fore Pharma announced the results of its Panic Disorder patients study in a new report ‘Global Panic Disorder Epidemiology and Patient Flow Analysis - 2017’. The report provides insights into Panic ...

  • Industries : Mental Health, Pathology
  • Countries : World, United States, Germany, France, Spain, Italy, United Kingdom, Japan
Europe Schizophrenia Epidemiology and Patient Flow Analysis - 2017

Europe Schizophrenia Epidemiology and Patient Flow Analysis - 2017

  • $ 1390
  • Industry report
  • January 2017

Fore Pharma announced the results of its Schizophrenia patients study in a new report ‘Europe Schizophrenia Epidemiology and Patient Flow Analysis - 2017’. The report provides insights into Schizophrenia ...

  • Industries : Mental Health, Pathology
  • Countries : Europe, Germany, France, Spain, Italy, United Kingdom
Global Bipolar Disorder Epidemiology and Patient Flow Analysis - 2017

Global Bipolar Disorder Epidemiology and Patient Flow Analysis - 2017

  • $ 1790
  • Industry report
  • January 2017

Fore Pharma announced the results of its Bipolar Disorder patients study in a new report ‘Global Bipolar Disorder Epidemiology and Patient Flow Analysis - 2017’. The report provides insights into Bipola ...

  • Industries : Mental Health, Pathology
  • Countries : World, United States, Germany, France, Spain, Italy, United Kingdom, Japan
Global Parkinson%s Disease Epidemiology and Patient Flow Analysis - 2017

Global Parkinson%s Disease Epidemiology and Patient Flow Analysis - 2017

  • $ 1790
  • Industry report
  • January 2017

Fore Pharma announced the results of its Parkinson's Disease patients study in a new report ‘Global Parkinson's Disease Epidemiology and Patient Flow Analysis - 2017’. The report provides insights ...

  • Industries : Mental Health, Pathology
  • Countries : World, United States, Germany, France, Spain, Italy, United Kingdom, Japan
Global Alzheimer%s Disease Epidemiology and Patient Flow Analysis - 2017

Global Alzheimer%s Disease Epidemiology and Patient Flow Analysis - 2017

  • $ 1790
  • Industry report
  • January 2017

Fore Pharma announced the results of its Alzheimer's Disease patients study in a new report ‘Global Alzheimer's Disease Epidemiology and Patient Flow Analysis - 2017’. The report provides insights ...

  • Industries : Mental Health, Pathology
  • Countries : World, United States, Germany, France, Spain, Italy, United Kingdom, Japan
96 reports

Download Unlimited Documents from Trusted Public Sources

Gaming Industry in Europe and Spain

  • January 2019
    80 pages
  • Gaming  

    Online Gambling  

    Addiction Disor...  

  • Europe  

    Spain  

View report >

Hospital Markets December 2018


ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on